Navigation Links
Amylin Pharmaceuticals Reports First Quarter Financial Results
Date:4/16/2009

Non-GAAP Operating Loss Improves by 55% to $19.9 Million Compared to the First Quarter of 2008

Amylin/Lilly Alliance Restructures Exenatide Operations: Team to Co-locate in San Diego

SAN DIEGO, April 16 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN) today reported financial results for the quarter ended March 31, 2009. The Company reported total revenue of $193.7 million for the quarter ended March 31, 2009, which includes net product sales of $179.3 million, including a $5.8 million reserve related to the U.S. Department of Defense's Tricare Retail Pharmacy program described below. Non-GAAP operating loss was $19.9 million for the quarter ended March 31, 2009, compared to $44.0 million for the same period in 2008. GAAP net loss was $47.0 million, or $0.34 per share, for the quarter ended March 31, 2009, compared to $71.1 million, or $0.52 per share, for the same period in 2008. At March 31, 2009 the Company held cash, cash equivalents and short-term investments of $711.4 million.

"At the end of 2008, we announced that we would manage operating expenses more in line with revenue as part of the business plan to achieve positive operating cash flow by the end of 2010," said Mark Foletta, senior vice president of finance and chief financial officer, Amylin Pharmaceuticals. "This quarter's reduction of non-GAAP operating loss by more than half compared to the same quarter last year demonstrates steady progress toward that goal."

Financial Results

Net product sales of $179.3 million for the quarter ended March 31, 2009 include $157.7 million for BYETTA(R) (exenatide) injection and $21.6 million for SYMLIN(R) (pramlintide acetate) injection. This compares to net product sales of $178.7 million, consisting of $158.5 million for BYETTA and $20.2 million for SYMLIN
'/>"/>

SOURCE Amylin Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Letter From Carl Icahn to Amylin Pharmaceutical, Inc.
2. Amylin Pharmaceuticals to Webcast First Quarter Results
3. Amylin Pharmaceuticals Announces Slate of Directors for Annual Meeting of Stockholders
4. Amylin Pharmaceuticals Comments on Shareholder 13-D Filing
5. Amylin Pharmaceuticals Reports 2008 Financial Results
6. Amylin Pharmaceuticals to Webcast Year-End Results
7. Amylin Pharmaceuticals to Present at JPMorgan Healthcare Conference
8. Amylin, Lilly Update on FDA Review of BYETTA(R) (exenatide) Injection Monotherapy Submission
9. Amylin Pharmaceuticals to Present at Lazard Capital Markets Healthcare Conference
10. Lilly and Amylin Set Date and Time for Conference Call
11. Amylin Pharmaceuticals Diabetes Drug Byetta the Focus of California Lawsuit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Salt Lake City, UT (PRWEB) March 30, 2015 ... for Americans to take stock of their eating habits and ... and long-term health in the future. According to a recent ... of daily calorie intake comes from snack food. Making healthy ... well-balanced diet, even for a busy society constantly on the ...
(Date:3/29/2015)... 30, 2015 Elfster.com, the top-rated Secret ... its promotional plans to publicize its gift exchange generator ... season. Known as the leader in Secret Santa online ... that adjacent markets can see the opportunities as well. ... awareness," explained Peter Imburg, CEO of Elster.com. "With Christmas ...
(Date:3/29/2015)... The culmination of one of the most exciting sporting ... Four invades Lucas Oil Stadium in Indianapolis IN. The ... excitement, buzzer-beaters, and of course, upsets. Throughout the dozens of ... and future professional products have been seen. In the end, ... that advanced through their regional bracket with the hopes of ...
(Date:3/29/2015)... (PRWEB) March 29, 2015 Youth Villages ... counties in Oregon to assess the feasibility of implementing ... emotional and behavioral problems and their families. , Third ... select participants that will be provided technical assistance throughout ... counties join six other national awardees chosen by Third ...
(Date:3/28/2015)... 28, 2015 Coffee could not only perk ... you from gum disease, researchers have found. , They found ... , Coffee contains antioxidants. Antioxidants fight gum disease. Does coffee, ... at Boston Univ. Henry M. Goldman School of Dental Medicine ... 2014 issue of the Journal of Periodontology. , “This is ...
Breaking Medicine News(10 mins):Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 2Health News:Benefits of Healthy Snacking — HealthyYOU Vending Machines Offer 21 Healthy Snack Selections for People on the Go 3Health News:Gift Exchange Generator Promotion Achieves Early Success, Announces Elfster 2Health News:Cheap 2015 Final Four Tickets: Ticket Down Slashes Kentucky Wildcats and Wisconsin Badgers Final Four Tickets at Lucas Oil Stadium and Issues Valuable Promo Code 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 2Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 3Health News:Youth Villages Partners with Two Oregon Counties to Advance Pay-for-Success Model to Help At-Risk Youth 4Health News:New Research Impliments Coffee May Help Fight Gum Disease and Increasing Benefits With Tylers Coffee 2
... The past decade has seen a sharp rise in the ... over the globe to scientifically document the effects of hundreds ... was// no easy access to current, comprehensive information about these ... York City have now created a new website which will ...
... "erythropoietin", a genetically engineered drug, has recently been found ... have been administered with this drug. This drug introduced ... patients with kidney disease. //The disease, called Pure Red ... number of people and patients affected with this disease ...
... (Laser in Situ Keratomilensis), is the most widely performed ... short sightedness (Myopia), farsightedness (Hyperopia) and even astigmatism. The ... a special piece of equipment called Exlimer laser., ... you meet the following criteria. ,(a) Enjoy general good ...
... hair need about 30 percent more anesthesia than patients ,with ... red may also make carrot-tops harder to knock out -- ... anaesthesia// to make them lose consciousness. Although anaesthetics have been ... little about how they really work. A study by doctors ...
... tend to harbor genetic defects that will disturb their ... reproductive cloning of humans should be banned.// However, the ... for therapeutic cloning techniques, such as producing embryonic stem ... Cloned animals have major dysregulation of multiple ...
... growing body of evidence that adult health is set to ... that programming may start earlier in pregnancy than previously believed. ... shorter thigh bones// at 24weeks had higher blood pressure at ... ,Understanding how life in the womb influences later ...
Cached Medicine News:Health News:New insights into herbal supplements 2Health News:Lasik surgery effective in correcting vision 2Health News:Genetic failure in cloned animals 2Health News:Womb may have impact upon Blood Pressure 2Health News:Womb may have impact upon Blood Pressure 3
(Date:3/27/2015)... , March 27, 2015  WebMD ... leading source of health information, today announced ... new National Action Plan for Combating ... Obama emphasized the urgency and importance of ... national and global health.    The ...
(Date:3/26/2015)... /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the ... Omega-3 therapies for cardiovascular disease and overall health, announced ... shares of the Corporation (the "Common Shares"). The Common ... December 5 th , 2014 to March 4 th ... due on or before April 1, 2015. Interest on ...
(Date:3/26/2015)... , March 26, 2015 "Whether it,s our ... one day." In a single sentence, ... scientific officer at Pfizer,s Centers for Therapeutic Innovation ... scientists fueling progress at America,s biopharmaceutical companies. ... side-by-side with academia, patient foundations and the National Institutes ...
Breaking Medicine Technology:Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 2Exclusive: WebMD Interviews President Obama About Plan for Combating Antibiotic Resistance 3Pivotal Therapeutics announces payment of interest on outstanding convertible notes 2Collaboration for Cures: Teaming Up to Advance Science and Save Lives 2
... Pain relieving effects of MoxDuo(TM) IR are ... with post-operative pain following total knee replacement , ... QRxPharma Limited (ASX: QRX) and (OTCQX: QRXPY) announced today ... efficacy and safety profile of MoxDuo(TM) IR (immediate release) capsules ...
... , THOUSAND OAKS, Calif., Aug. 25 Amgen (Nasdaq: ... double-blind, placebo-controlled, Phase 3 study of patients with chronic kidney disease ... rial to R educe Cardiovascular E ndpoints with ... Aranesp((R) )(darbepoetin alfa) to a hemoglobin target of 13 g/dL had ...
Cached Medicine Technology:MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R) 2MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R) 3MoxDuo(TM) IR Demonstrates Fewer Side Effects Than Percocet(R) 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 2Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 3Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 6Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 7Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 8
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: